Suchergebnisse - "Rovesti, Giulia"

PubPharm (42)

1

Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma

enthalten in: NPJ precision oncology | 2024

von Chiavelli, C. | Prapa, M. | Rovesti, G. | +20

2

A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting : the ECSIPOT Index

enthalten in: Journal of gastrointestinal cancer | 2022

von Rovesti, G. | Leone, F. | Brandi, G. | +26

3

Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients : the PECS Index

enthalten in: Journal of gastrointestinal cancer | 2022

von Rovesti, G. | Leone, F. | Brandi, G. | +27

4

Process Development for Adoptive Cell Therapy in Academia : A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products

enthalten in: Frontiers in immunology | 2022

von Silva, D. | Chrobok, M. | Rovesti, G. | +11

5

Process development for adoptive cell therapy in academia : a pipeline for clinical-scale manufacturing of multiple TCR-T cell products

enthalten in: Frontiers in immunology | 16 June 2022

von Silva, D. | Chrobok, M. | Rovesti, G. | +11

6

Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus

enthalten in: Tumori | 2021

von Pretta, A. | Ziranu, P. | Puzzoni, M. | +22

7

A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy

enthalten in: Acta oncologica (Stockholm, Sweden) | 2021

von Filippi, R. | Montagnani, F. | Lombardi, P. | +16

8

Clinical Implications of Malnutrition in the Management of Patients with Pancreatic Cancer : Introducing the Concept of the Nutritional Oncology Board

enthalten in: Nutrients | 2021

von Rovesti, G. | Valoriani, F. | Rimini, M. | +6

9

Liquid Biopsy in Hepatocellular Carcinoma : Opportunities and Challenges for Immunotherapy

enthalten in: Cancers | 2021

von Maravelia, P. | Silva, D. | Rovesti, G. | +4

10

Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib

enthalten in: HPB : the official journal of the International Hepato Pancreato Biliary Association | 2021

von Casadei-Gardini, A. | Rovesti, G. | Dadduzio, V. | +13

1
2
3
4
5
Nächster »
[5]